PHARMACEUTICAL COMPOSITION CONTAINING N-CHLOROPHENYLCARBAMATE OR N- CHLOROPHENYLTHIOCARBAMATE, COMPOSITION OF STANDARD MEDICINAL FORMULA AND METHOD OF TREATMENT OF CANCER PATIENTS Russian patent published in 2001 - IPC

Abstract RU 2170577 C2

FIELD: medicine, oncology, pharmacy. SUBSTANCE: invention relates to pharmaceutical composition inhibiting growth of malignant neoplasms and tumors in mammals, in part, in humans and warm-blooded animals and method of treatment of cancer patients. Composition shows efficiency against viruses also. Composition has N-chlorophenylcarbamates and N-chlorophenyl-thiocarbamates that are systemic herbicides. Composition can include except for N-chlorophenylcarbamates and N-chloro- phenylthiocarbamates also chemotherapeutic agents and, optionally, potentiating agent. Invention describes also the composition for treatment of animals and humans with viral infections that includes effective amount of N- chlorophenyl-carbamates and N-chlorophenylthiocarbamates and potentiating agent. Composition shows effect without action or with mild action on normal cells. EFFECT: enhanced effectiveness of composition, valuable anticancer and antiviral properties. 17 cl, 2 tbl

Similar patents RU2170577C2

Title Year Author Number
PHARMACEUTICAL COMPOSITION, COMPOSITION OF STANDARD MEDICINAL FORM AND METHOD OF TREATMENT OF MALIGNANT NEOPLASM, TUMOR AND VIRAL INFECTION 1996
  • Kehmden Dzhejms Berger
RU2197964C2
PHARMACEUTICAL COMPOSITION CONTAINING N-CHLOROPHENYLCARBAMATES OR N- CHLOROPHENYLTHIOCARBAMATES AND DERIVATIVES OF N-PHOSPHO-NOGLYCINE FOR INHIBITION OF MALIGNANT NEOPLASMS GROWTH AND VIRUSES IN MAMMALS 1996
  • Kehmden Dzhejms Berger
RU2170578C2
PHARMACEUTICAL COMPOSITION FOR CANCER AND VIRAL DISEASE TREATMENT, METHOD OF CANCER TREATMENT, METHOD OF VIRAL INFECTION TREATMENT BASED ON THEREOF 1996
  • Kehmden Dzhejms Berger
RU2177316C2
PHARMACEUTICAL COMPOSITION FOR OSTEOINDUCTION AND METHOD FOR GENERATION OF A NEW BONE 1992
  • Rodzher Li Stoun[Us]
RU2107512C1
AGONISTS OF CORTICOTROPIN-RELEASING FACTOR RECEPTOR 2003
  • Isfort Robert Dzhozef
  • Mazur Uislo Adam
RU2286995C2
AGONISTS OF CORTICOTROPIN-RELEASING FACTOR (CRFR) RECEPTOR AND THEIR USING 2003
  • Isfort Robert Dzhozef
  • Mazur Uislo Adam
RU2294333C2
COMPOSITION FOR TEETH CLEANSING 1995
  • Dehvid Ehrl Rajs
RU2155579C2
CORTICOTROPIN-RELEASING FACTOR RECEPTOR AGONISTS AND USES THEREOF 2003
  • Isfort Robert Dzhozef
  • Mazur Uislo Adam
RU2305110C2
DERIVATIVES OF 5-(2-IMIDAZOLINYLAMINO)-BENZIMIDAZOLE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 1994
  • Tomas Li Kapps
  • Sofi Eva Bogdan
RU2143430C1
PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION FOR TREATMENT OF PATIENTS WITH PATHOLOGY OF GASTROENTERIC TRACT UPPER REGIONS 1992
  • Dzhejms Grigg Apson
  • Karmelita Makklin Rassel
RU2126249C1

RU 2 170 577 C2

Authors

Kehmden Dzhejms Berger

Dates

2001-07-20Published

1996-04-11Filed